SS
Samantha Semenkow Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
70.6%
Neutral
29.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $5 |
51%
downside
| 1 | – |
–
| 30 Sep ‘25 12 days ago |
|
|
|
Buy
Initiated
| $28 |
77%
upside
| 1 | +17% |
0
%
| 17 Sep ‘25 25 days ago |
|
|
|
Buy
Initiated
| $16 |
0%
downside
| 1 | +34% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $10 |
331%
upside
| 2 | +15% |
0
%
| 14 Aug ‘25 1 month ago |
|
|
|
Buy
Initiated
| $16 |
111%
upside
| 1 | -1.4% |
0
%
| 16 Jul ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $1.50 |
74%
downside
| 1 | – |
–
| 27 May ‘25 4 months ago |
|
|
|
Buy
Maintained
| $4 |
225%
upside
| 1 | +29% |
0
%
| 15 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $803 |
1%
upside
| 3 | +15% |
0
%
| 9 May ‘25 5 months ago |
|
|
|
Buy
Initiated
| $60 |
100%
upside
| 1 | +10% |
0
%
| 2 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $5 |
7%
downside
| 3 | -16% |
0
%
| 24 Mar ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $3 |
32%
upside
| 1 | – |
–
| 7 Jan ‘25 9 months ago |
|
|
|
Buy
Initiated
| $12 |
140%
upside
| 1 | -27% |
0
%
| 2 Dec ‘24 10 months ago |
|